Literature DB >> 26378181

Differential Reovirus-Specific and Herpesvirus-Specific Activator Protein 1 Activation of Secretogranin II Leads to Altered Virus Secretion.

Alicia R Berard1, Alberto Severini2, Kevin M Coombs3.   

Abstract

UNLABELLED: Viruses utilize host cell machinery for propagation and manage to evade cellular host defense mechanisms in the process. Much remains unknown regarding how the host responds to viral infection. We recently performed global proteomic screens of mammalian reovirus TIL- and T3D-infected and herpesvirus (herpes simplex virus 1 [HSV-1])-infected HEK293 cells. The nonenveloped RNA reoviruses caused an upregulation, whereas the enveloped DNA HSV-1 caused a downregulation, of cellular secretogranin II (SCG2). SCG2, a member of the granin family that functions in hormonal peptide sorting into secretory vesicles, has not been linked to virus infections previously. We confirmed SCG2 upregulation and found SCG2 phosphorylation by 18 h postinfection (hpi) in reovirus-infected cells. We also found a decrease in the amount of reovirus secretion from SCG2 knockdown cells. Similar analyses of cells infected with HSV-1 showed an increase in the amount of secreted virus. Analysis of the stress-activated protein kinase (SAPK)/Jun N-terminal protein kinase (JNK) pathway indicated that each virus activates different pathways leading to activator protein 1 (AP-1) activation, which is the known SCG2 transcription activator. We conclude from these experiments that the negative correlation between SCG2 quantity and virus secretion for both viruses indicates a virus-specific role for SCG2 during infection. IMPORTANCE: Mammalian reoviruses affect the gastrointestinal system or cause respiratory infections in humans. Recent work has shown that all mammalian reovirus strains (most specifically T3D) may be useful oncolytic agents. The ubiquitous herpes simplex viruses cause common sores in mucosal areas of their host and have coevolved with hosts over many years. Both of these virus species are prototypical representatives of their viral families, and investigation of these viruses can lead to further knowledge of how they and the other more pathogenic members of their respective families interact with the host. Here we show that secretogranin II (SCG2), a protein not previously studied in the context of virus infections, alters virus output in a virus-specific manner and that the quantity of SCG2 is inversely related to amounts of infectious-virus secretion. Herpesviruses may target this protein to facilitate enhanced virus release from the host.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26378181      PMCID: PMC4645345          DOI: 10.1128/JVI.01639-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

Review 1.  The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation.

Authors:  P Angel; M Karin
Journal:  Biochim Biophys Acta       Date:  1991-12-10

2.  Activation of small GTPases RhoA and Rac1 is required for avian reovirus p10-induced syncytium formation.

Authors:  Hung-Jen Liu; Ping-Yuan Lin; Ling-Rung Wang; Hsue-Yin Hsu; Ming-Huei Liao; Wen-Ling Shih
Journal:  Mol Cells       Date:  2008-07-07       Impact factor: 5.034

3.  Immunohistochemical distribution of the secretogranin II-derived peptide EM66 in the rat hypothalamus: a comparative study with jerboa.

Authors:  Mohammed Boutahricht; Johann Guillemot; Maité Montero-Hadjadje; Youssef Barakat; Seloua El Ouezzani; Abdelilah Alaoui; Laurent Yon; Hubert Vaudry; Youssef Anouar; Rabia Magoul
Journal:  Neurosci Lett       Date:  2006-12-29       Impact factor: 3.046

Review 4.  The regulation of AP-1 activity by mitogen-activated protein kinases.

Authors:  M Karin
Journal:  J Biol Chem       Date:  1995-07-14       Impact factor: 5.157

5.  Monensin and brefeldin A differentially affect the phosphorylation and sulfation of secretory proteins.

Authors:  P Rosa; S Mantovani; R Rosboch; W B Huttner
Journal:  J Biol Chem       Date:  1992-06-15       Impact factor: 5.157

6.  Herpes simplex virus type 1 infection stimulates p38/c-Jun N-terminal mitogen-activated protein kinase pathways and activates transcription factor AP-1.

Authors:  G Zachos; B Clements; J Conner
Journal:  J Biol Chem       Date:  1999-02-19       Impact factor: 5.157

7.  Sorting of the neuroendocrine secretory protein Secretogranin II into the regulated secretory pathway: role of N- and C-terminal alpha-helical domains.

Authors:  Maïté Courel; Michael S Vasquez; Vivian Y Hook; Sushil K Mahata; Laurent Taupenot
Journal:  J Biol Chem       Date:  2008-02-25       Impact factor: 5.157

Review 8.  Chromogranins A and B and secretogranin II: evolutionary and functional aspects.

Authors:  M Montero-Hadjadje; S Vaingankar; S Elias; H Tostivint; S K Mahata; Y Anouar
Journal:  Acta Physiol (Oxf)       Date:  2007-11-15       Impact factor: 6.311

9.  Secretogranin II: a key AP-1-regulated protein that mediates neuronal differentiation and protection from nitric oxide-induced apoptosis of neuroblastoma cells.

Authors:  L Li; A C Hung; A G Porter
Journal:  Cell Death Differ       Date:  2008-02-01       Impact factor: 15.828

10.  Growth of an RNA virus in single cells reveals a broad fitness distribution.

Authors:  Ying Zhu; Andrew Yongky; John Yin
Journal:  Virology       Date:  2008-12-13       Impact factor: 3.616

View more
  2 in total

1.  JNK1 Derived from Orange-Spotted Grouper, Epinephelus coioides, Involving in the Evasion and Infection of Singapore Grouper Iridovirus (SGIV).

Authors:  Minglan Guo; Jingguang Wei; Xiaohong Huang; Yongcan Zhou; Yang Yan; Qiwei Qin
Journal:  Front Microbiol       Date:  2016-02-10       Impact factor: 5.640

2.  Secretogranin II impairs tumor growth and angiogenesis by promoting degradation of hypoxia-inducible factor-1α in colorectal cancer.

Authors:  Chao Fang; Lei Dai; Cun Wang; Chuanwen Fan; Yongyang Yu; Lie Yang; Hongxin Deng; Zongguang Zhou
Journal:  Mol Oncol       Date:  2021-07-26       Impact factor: 6.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.